Abstract
Acute osteomyelitis and septic arthritis are two infections whose frequencies are increasing in pediatric patients. Acute osteomyelitis and septic arthritis need to be carefully assessed, diagnosed, and treated to avoid devastating sequelae. Traditionally, the treatment of acute osteoarticular infection in pediatrics was based on prolonged intravenous anti-infective therapy. However, results from clinical trials have suggested that in uncomplicated cases, a short course of a few days of parenteral antibiotics followed by oral therapy is safe and effective. The aim of this review is to provide clinicians an update on recent controversies and advances regarding the management of acute osteomyelitis and septic arthritis in children. In recent years, the emergence of bacterial species resistant to commonly used antibiotics that are particularly aggressive highlights the necessity for further research to optimize treatment approaches and to develop new molecules able to fight the war against acute osteoarticular infection in pediatric patients.
Highlights
Acute osteomyelitis and septic arthritis represent two inflammatory diseases that affect bone and synovial joints and are both primarily caused by bacterial infection [1,2,3]
The aim of this review is to provide clinicians an update on recent controversies and advances regarding the management of acute osteomyelitis and septic arthritis in children
Antibiotic therapy is the gold standard for treating acute osteomyelitis and septic arthritis
Summary
Acute osteomyelitis and septic arthritis represent two inflammatory diseases that affect bone and synovial joints and are both primarily caused by bacterial infection [1,2,3]. These two diseases can occur alone or in combination. Acute osteomyelitis and septic arthritis, not so frequent, should not be underestimated because they could be associated with sepsis and with sequelae such as joint destruction, growth failure, and death of the patient if they are not correctly treated [7,8]. The aim of this review is to provide clinicians an update on recent controversies and advances regarding the management of acute osteomyelitis and septic arthritis in children
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.